Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer
Latest Information Update: 13 Jan 2023
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms COG-PRO
- 10 Jan 2023 Status changed from active, no longer recruiting to completed.
- 28 Mar 2022 Status changed from recruiting to active, no longer recruiting.
- 10 Dec 2021 Planned End Date changed from 1 Nov 2022 to 1 Nov 2023.